Church & Dwight and Clorox are two well-known names in the household and personal care products industry, but they occupy meaningfully different positions in the current market. This stock comparison is useful for investors and traders evaluating how two consumer staples businesses with distinct growth profiles, valuation multiples, and risk factors stack up against one another. While both operate in defensive categories such as cleaning, laundry, and health products, their recent momentum, market positioning, and sentiment have diverged. The analysis below reviews each company's business context, recent relative performance, and the factors currently shaping investor expectations.
CHD, or Church & Dwight Co., Inc., is the leading U.S. producer of baking soda and owns brands including Arm & Hammer, OxiClean, TheraBreath, Hero, Batiste, and Touchland. The company derives roughly 80% of its sales from the U.S. and has been reshaping its portfolio by exiting slower-growing businesses, such as its vitamin brands, while acquiring faster-growing assets including hand-sanitizer maker Touchland and stain-removal brand Miss Mouth's Messy Eater.
In recent market activity, CHD has shown resilience but has not been immune to selling pressure. The stock delivered positive year-to-date gains, supported by strong quarterly results that featured organic sales growth well above management's initial guidance, driven by volume. However, in recent weeks the shares pulled back from their highs amid a broader pause in momentum. Analysts have cited a premium valuation—roughly 26 times forward earnings—as a key consideration, even as the company's gross margin expansion and 30th consecutive annual dividend increase underscore its financial discipline.
CLX, or The Clorox Company, manufactures cleaning, disinfecting, food, and personal care products under brands such as Clorox, Pine-Sol, Glad, Fresh Step, Hidden Valley, Brita, and Burt's Bees. The company recently completed the final phase of its U.S. ERP (enterprise resource planning) system rollout and closed its acquisition of GOJO Industries, owner of the Purell hand-sanitizer brand.
Clorox's recent stock behavior has been notably weak. The shares have fallen sharply over recent months and trade below their 50-day and 200-day moving averages. Much of the decline reflects transitory factors: retailers drew down inventory that had been built up ahead of the ERP transition, weighing on reported sales and earnings, and the company issued a voluntary product recall during the period. The stock now offers a dividend yield near 6%, reflecting both a higher payout and a lower share price. Analysts hold a predominantly "Hold" consensus rating as the market weighs these short-term disruptions against the company's longer-term transformation efforts.
Tickeron's Trending AI Robots page is a curated showcase of the platform's most relevant automated trading strategies for current market conditions. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, but only those bots whose performance, strategy, and statistics align best with today's environment earn a place in this featured section. These bots vary widely in trading style, strategy, timeframe, performance metrics, and the sets of tickers they follow—ranging from short-term swing strategies to longer-horizon trend-following approaches. This diversity allows traders and investors to screen for automation that matches their own risk tolerance and outlook. Explore the Trending AI Robots to see which strategies are currently standing out.
The two companies diverge most clearly on growth trajectory and valuation. CHD is oriented around volume-led organic growth, premiumization, and disciplined acquisitions in faster-moving categories such as oral care and acne treatment. Its shares command a higher earnings multiple—reflecting that growth expectation—but pay a comparatively small dividend. CLX, by contrast, is a more mature, cash-generative business whose near-term results are distorted by the ERP transition and inventory drawdown. It trades at a lower earnings multiple and carries a much higher dividend yield, though the elevated payout has at times absorbed nearly all of its free cash flow.
Risk profiles also differ. CLX faces balance-sheet leverage and tighter dividend coverage following its GOJO acquisition, along with concentrated exposure to categories showing soft demand. CHD's main risks center on premium valuation, rising marketing costs, and competitive pressure from private-label brands. In terms of market sentiment, CHD has held up better despite a recent pullback, while CLX's technical posture remains bearish relative to the staples sector.
Based on observable factors, Tickeron's AI would currently lean toward CHD. The company's relative strength lies in more consistent trend behavior, volume-led organic growth, expanding margins, and a steadier earnings trajectory. CLX, while inexpensive on a valuation basis and offering a compelling dividend yield, is contending with transitory operational disruptions, weaker relative momentum, and higher balance-sheet risk. This assessment is probabilistic rather than definitive: it reflects current momentum, stability, and positioning, and could shift as Clorox's ERP-related headwinds fade and its GOJO integration matures.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CHD saw its Momentum Indicator move above the 0 level on October 05, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In 57 of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at 61%.
The Moving Average Convergence Divergence (MACD) for CHD just turned positive on October 05, 2026. Looking at past instances where CHD's MACD turned positive, the stock continued to rise in 29 of 52 cases over the following month. The odds of a continued upward trend are 56%.
CHD moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHD advanced for three days, in 171 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
The Aroon Indicator entered an Uptrend today. In 103 of 232 cases where CHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 44%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for CHD crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
CHD broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 31 (best 1 - 100 worst), indicating outstanding price growth. CHD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.216) is normal, around the industry mean (18.044). P/E Ratio (30.647) is within average values for comparable stocks, (43.673). Projected Growth (PEG Ratio) (2.688) is also within normal values, averaging (1.518). Dividend Yield (0.013) settles around the average of (0.024) among similar stocks. P/S Ratio (3.676) is also within normal values, averaging (1.931).
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
CLX saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned positive. In 56 of the 98 cases, the stock moved higher in the following days. The odds of a move higher are at 57%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLX's RSI Oscillator exited the oversold zone, 17 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Moving Average Convergence Divergence (MACD) for CLX just turned positive on October 05, 2026. Looking at past instances where CLX's MACD turned positive, the stock continued to rise in 24 of 48 cases over the following month. The odds of a continued upward trend are 50%.
Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLX advanced for three days, in 184 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for CLX entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. CLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLX's P/B Ratio (109.890) is slightly higher than the industry average of (18.044). P/E Ratio (16.927) is within average values for comparable stocks, (43.673). Projected Growth (PEG Ratio) (1.019) is also within normal values, averaging (1.518). CLX has a moderately high Dividend Yield (0.061) as compared to the industry average of (0.024). P/S Ratio (1.542) is also within normal values, averaging (1.931).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
CHD | CLX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 25 | 22 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 55 | 100 | |
SMR RATING 1..100 | 52 | 10 | |
PRICE GROWTH RATING 1..100 | 31 | 62 | |
P/E GROWTH RATING 1..100 | 69 | 50 | |
SEASONALITY SCORE 1..100 | 85 | 33 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CHD's Valuation (69) in the Household Or Personal Care industry is in the same range as CLX (78). This means that CHD’s stock grew similarly to CLX’s over the last 12 months.
CHD's Profit vs Risk Rating (55) in the Household Or Personal Care industry is somewhat better than the same rating for CLX (100). This means that CHD’s stock grew somewhat faster than CLX’s over the last 12 months.
CLX's SMR Rating (10) in the Household Or Personal Care industry is somewhat better than the same rating for CHD (52). This means that CLX’s stock grew somewhat faster than CHD’s over the last 12 months.
CHD's Price Growth Rating (31) in the Household Or Personal Care industry is in the same range as CLX (62). This means that CHD’s stock grew similarly to CLX’s over the last 12 months.
CLX's P/E Growth Rating (50) in the Household Or Personal Care industry is in the same range as CHD (69). This means that CLX’s stock grew similarly to CHD’s over the last 12 months.
| CHD | CLX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 50% | 2 days ago 49% |
| Stochastic ODDS (%) | 2 days ago 48% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 56% | 2 days ago 50% |
| TrendWeek ODDS (%) | 2 days ago 50% | 2 days ago 52% |
| TrendMonth ODDS (%) | 2 days ago 48% | 2 days ago 62% |
| Advances ODDS (%) | 2 days ago 50% | 2 days ago 57% |
| Declines ODDS (%) | 15 days ago 48% | 14 days ago 60% |
| BollingerBands ODDS (%) | 2 days ago 55% | N/A |
| Aroon ODDS (%) | 2 days ago 44% | 2 days ago 61% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHD’s FA Score shows that 1 FA rating(s) are green while CLX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHD’s TA Score shows that 5 TA indicator(s) are bullish while CLX’s TA Score has 4 bullish TA indicator(s).
CHD (@Household/Personal Care) experienced а +6.08% price change this week, while CLX (@Household/Personal Care) price change was +3.36% for the same time period.
The average weekly price growth across all stocks in the @Household/Personal Care industry was +66.23%. For the same industry, the average monthly price growth was +55.60%, and the average quarterly price growth was +49.68%.
CHD is expected to report earnings on Oct 30, 2026.
CLX is expected to report earnings on Nov 02, 2026.
Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MMAX | 27.53 | -0.02 | -0.06% |
| iShares Large Cap Max Buffer Mar ETF (MMAX) | |||
| IBMX | 23.67 | -0.03 | -0.11% |
| iShares iBonds Dec 2035 Term Muni Bond ETF (IBMX) | |||
| JHEM | 38.77 | -0.74 | -1.88% |
| John Hancock Multifactor Emerging Markets ETF (JHEM) | |||
| SMH | 564.74 | -23.38 | -3.98% |
| VanEck Semiconductor ETF (SMH) | |||
| SNDU | 16.43 | -1.94 | -10.56% |
| T-REX 2X Long SNDK Daily Target ETF (SNDU) | |||
A.I.dvisor indicates that over the last year, CLX has been loosely correlated with CHD. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLX jumps, then CHD could also see price increases.